| Autor: |
Giamarellou, H., Avlami, A., Matsakas, V., Kosmidis, J., Daikos, G. K. |
| Zdroj: |
Journal of Antimicrobial Chemotherapy (JAC); 1981, Vol. 8 Issue suppl_B, p73-77, 5p |
| Abstrakt: |
MIC determinations for 275 multiply-resistant nosocomial isolates of enterobacteria showed that ceftazidime was more effective than cefotaxime, cefoxitin or cephalothin. Enterobacter species were the most resistant with 12% isolates resistant to more than 8 mg/l of ceftazidime, but this was still the most active agent.Of 150 isolates of Pseudomonas aeruginosa (55% of which were resistant to gentamicin), only 9% were resistant to 8 mg/l of ceftazidime and 2% to cefsulodin, both of which were more active than cefotaxime, ceftriaxone, cefoperazone or moxalactam. Ceftazidime was less active than cefoxitin against Bacteroides fragilis, with 30% of strains resistant to 8 mg/l of ceftazidime, but it was more active than cefotaxime or cephalothin. [ABSTRACT FROM PUBLISHER] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
